Predicting Heart Disease: Do Polygenic Risk Scores Outperform Traditional Imaging?
Predicting cardiovascular disease (CVD) risk isn’t just about numbers on a chart; it’s about guiding life-saving decisions regarding preventive therapies. For years, clinicians have relied on traditional risk models, but the arrival of Polygenic Risk Scores (PRS) has introduced a new variable: our DNA. Even as the promise of genetic prediction is high, recent evidence suggests that traditional imaging still holds the upper hand for many patients.
- CAC Score Superiority: In middle-aged and older adults, the coronary artery calcium (CAC) score is more effective at predicting coronary heart disease (CHD) risk than polygenic risk scores.
- Traditional Model Boost: Adding a CAC score to traditional risk factors significantly improves risk discrimination, whereas adding PRS does not provide the same benefit.
- Youth Advantage: An integrated approach combining both CAC and PRS may offer better risk stratification for younger patients.
- Guideline Standards: The American College of Cardiology (ACC) and American Heart Association (AHA) continue to recommend Pooled Cohort Equations (PCE) for initial risk stratification.
The Role of Polygenic Risk Scores (PRS) in Heart Health
A Polygenic Risk Score (PRS) is essentially a weighted sum of risk across common genetic variants. Instead of looking for a single “broken” gene, PRS analyzes thousands of small variations across the genome to estimate a person’s predisposition to a specific condition, such as coronary heart disease.
The goal is to identify high-risk individuals long before clinical symptoms appear, allowing for earlier intervention. However, the transition from genetic data to clinical action requires rigorous validation to ensure these scores actually improve patient outcomes.
CAC Scores vs. PRS: Which Predicts Risk Better?
When comparing genetic predispositions to physical evidence of disease, the physical evidence often tells a clearer story. An analysis of two population-based cohorts of middle-aged and older adults found that the coronary artery calcium (CAC) score provided better discrimination for CHD risk prediction than PRS.
The reason is simple: CAC imaging provides a noninvasive assessment of subclinical atherosclerosis. While PRS tells you what might happen based on your DNA, a CAC score shows what has already happened by measuring the actual buildup of calcium in the coronary arteries. This integrates an individual’s lifetime exposure to both measured and unmeasured risk factors, providing a real-time snapshot of arterial health.
Improving Traditional Risk Models
Clinicians typically start with the Pooled Cohort Equations (PCE), recommended by the ACC and AHA. These equations guide the initiation of lipid-lowering pharmacotherapy—generally when the PCE risk is greater than 7.5%, or selectively for those with a risk between 5% and 7.4%.
However, traditional models can sometimes overestimate or underestimate a patient’s actual risk. According to research published in JAMA, adding a CAC score to these traditional risk factors significantly improves the ability to discriminate between high-risk and low-risk patients. Interestingly, adding PRS to the same traditional models did not yield the same improvement in risk discrimination for this demographic.
The Path Toward Integrated Risk Stratification
Despite the current superiority of CAC scores in older populations, PRS isn’t obsolete. The future of cardiovascular prevention likely lies in an integrative approach.
For younger patients, who may not yet have developed detectable calcium buildup in their arteries, PRS can be a powerful tool. By combining the genetic “blueprint” provided by PRS with the physical evidence of a CAC score, doctors can create a more comprehensive risk profile. This synergy allows for more precise risk stratification, potentially catching high-risk individuals decades before a cardiac event occurs.
Comparison: CAC Score vs. Polygenic Risk Score
| Feature | CAC Score | Polygenic Risk Score (PRS) |
|---|---|---|
| Basis of Measurement | Physical calcium deposits in arteries | Weighted sum of genetic variants |
| What it Measures | Actual subclinical atherosclerosis | Genetic predisposition/lifetime risk |
| Primary Strength | High accuracy in middle-aged/older adults | Early identification in younger adults |
| Clinical Impact | Significantly improves traditional risk models | Provides baseline genetic risk stratification |
Frequently Asked Questions
What is a CAC score?
A coronary artery calcium (CAC) score is a noninvasive imaging tool that measures the amount of calcified plaque in the coronary arteries. It is used to assess the presence of subclinical atherosclerosis.
Can a genetic test replace a heart scan?
No. While Polygenic Risk Scores provide valuable information about your genetic predisposition, they do not indicate the actual state of your arteries. For middle-aged and older adults, imaging (like a CAC scan) is currently a more accurate predictor of immediate heart disease risk.
Who benefits most from an integrated approach?
Younger individuals may benefit most from combining PRS and CAC scores. Since they may not have developed visible plaque yet, the genetic score helps identify those who demand closer monitoring early in life.
Looking Ahead
The shift toward precision medicine means we are moving away from “one size fits all” risk charts. While the CAC score remains the gold standard for detecting existing arterial disease, the integration of genetic data through PRS offers a glimpse into a future where cardiovascular prevention is personalized from birth. By blending the “nature” of our genetics with the “nurture” of our lifestyle and clinical markers, clinicians can more accurately target interventions to those who need them most.